About this trial
The goal of this clinical trial is to investigate the effect of gastrointestinal stimulation with a pacemaker on the length of postoperative bowel paralysis in patients undergoing major abdominal surgery due to metastasizing colorectal cancer, appendiceal cancer or pseudomyxoma peritonei.
The main question it aims to answer is if the length of postoperative ileus is reduced when the gastrointestinal tract is stimulated with a pacemaker.
All participants will undergo cytoreductive surgery +/- heated intraperitoneal chemotherapy (the standard treatment for colorectal cancer, appendiceal cancer with peritoneal carcinomatosis or pseudomyxoma peritonei). After surgery, but before the abdomen is closed a pace lead will be attached to the stomach, exteriorized trough the abdominal wall and connected to an external pacemaker. The pacemaker is either turned on (experimental group) or off (control group).
After surgery, patients will be asked to fill out a diary on bowel movements once a day. Once normal bowel function is regained, the pace lead and pacemaker will be removed trough the abdominal wall with a firm pull.
Eligibility criteria
Qualifiers
Patients planned for elective cytoreductive surgery with or without heated intraperitoneal chemotherapy due to either colorectal or appendiceal cancer or with peritoneal metastases or due to pseudomyxoma peritonei
Written and orally informed consent
Over 18 years of age
Disqualifiers
Previous upper gastric or esophageal resection
History of difficulties in swallowing or gastrointestinal stenosis
Implanted or portable electrical medical device e.g. cardiac pacemaker, defibrillator or infusion pump etc.
Pregnant or breast-feeding women
Trial design
Treatments tested in this trial
- Gastric electrical stimulation
Treatment groups
Sponsors and collaborators
University of Aarhus
Lead sponsor
Danish Cancer Society
Collaborator